CARDIFF ONCOLOGY, INC. Adjustments to Additional Paid in Capital, Warrant Issued
CARDIFF ONCOLOGY, INC. (CRDF) reported Adjustments to Additional Paid in Capital, Warrant Issued of $55.57 thousand for the 12-month period ending 2007-01-31, per its 10-Q filed 2012-11-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2012-11-14
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|
| 2007-01-31 | $55.57K 10-Q · filed 2012-11-14 |
| 2006-01-31 | $222.19K 10-Q · filed 2012-11-14 |
| 2005-01-31 | $403.04K 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |